​

Elanco Animal Health (ELAN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ELAN Stock Forecast

Elanco Animal Health (ELAN) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $24.75, with a high of $32.00 and a low of $14.00. This represents a 16.20% increase from the last price of $21.30.

$10 $15 $20 $25 $30 $35 High: $32 Avg: $24.75 Low: $14 Last Closed Price: $21.3

ELAN Stock Rating

Elanco Animal Health stock's rating consensus is Buy, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (63.16%), 5 Hold (26.32%), 2 Sell (10.53%), and 0 Strong Sell (0.00%).

Buy
Total 19 0 2 5 12 Strong Sell Sell Hold Buy Strong Buy

ELAN Price Target Upside V Benchmarks

TypeNameUpside
StockElanco Animal Health16.20%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.02%

Price Target Trends

1M3M12M
# Anlaysts3511
Avg Price Target$27.33$26.80$21.82
Last Closing Price$21.30$21.30$21.30
Upside/Downside28.31%25.82%2.44%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 252103-116
Nov, 25284-115
Oct, 25186--15
Sep, 25185-115
Aug, 25186--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2025Barclays$30.00$21.6938.31%40.85%
Nov 20, 2025KeyBanc$27.00$21.4625.82%26.76%
Nov 19, 2025Argus Research$25.00$21.4616.50%17.37%
Nov 05, 2025Stifel Nicolaus$27.00$21.9123.23%26.76%
Oct 20, 2025UBS$25.00$21.6415.53%17.37%
Aug 08, 2025Andrea AlfonsoUBS$19.00$16.6713.98%-10.80%
Jul 17, 2025Steven MaddenCitigroup$32.00$14.79116.36%50.23%
Jul 17, 2025Rajat GuptaJ.P. Morgan$14.00$14.79-5.34%-34.27%
Jul 17, 2025Daniel ClarkLeerink Partners$18.00$14.7921.70%-15.49%
May 07, 2025Daniel ClarkLeerink Partners$11.00$9.5115.67%-48.36%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025KeyBancOverweightOverweighthold
Dec 08, 2025BarclaysOverweightOverweightinitialise
Nov 20, 2025KeyBancOverweightinitialise
Oct 20, 2025UBSBuyBuyhold
Aug 11, 2025Piper SandlerNeutralNeutralhold
Aug 08, 2025UBSBuyBuyhold
Jul 17, 2025Wells FargoEqual-Weightupgrade
Jun 26, 2025William BlairOutperformupgrade
May 21, 2025Cowen & Co.BuyBuyhold
Dec 09, 2024UBSBuyinitialise

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.27$-0.97$-0.15$-2.50$0.68----
Avg Forecast$0.45$1.01$1.04$0.92$0.91$0.90$1.05$1.22$1.44
High Forecast$0.46$1.02$1.06$0.95$0.92$0.99$2.32$1.49$1.47
Low Forecast$0.44$0.99$1.03$0.91$0.90$0.82$0.28$0.86$1.42
Surprise %-382.22%-196.04%-114.42%-371.74%-25.27%----

Revenue Forecast

$3B $4B $4B $5B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.27B$4.76B$4.42B$4.42B$4.44B----
Avg Forecast$3.19B$4.75B$4.41B$4.39B$4.42B$4.54B$4.75B$5.03B$5.28B
High Forecast$3.21B$4.79B$4.45B$4.40B$4.44B$4.57B$4.75B$5.04B$5.36B
Low Forecast$3.15B$4.70B$4.38B$4.38B$4.34B$4.49B$4.75B$5.01B$5.23B
Surprise %2.66%0.21%0.19%0.72%0.35%----

Net Income Forecast

$-2B $-1B $-600M $100M $800M $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-560.10M$-472.00M$-74.00M$-1.23B$338.00M----
Avg Forecast$-432.65M$-378.78M$-141.47M$-1.23B$450.17M$445.93M$639.60M$578.20M$710.55M
High Forecast$-346.12M$-303.02M$-94.52M$-822.50M$455.07M$487.35M$1.14B$732.39M$722.92M
Low Forecast$-519.18M$-454.53M$-188.41M$-1.64B$445.28M$404.50M$137.76M$424.01M$700.70M
Surprise %29.46%24.61%-47.69%--24.92%----

ELAN Forecast FAQ

Is Elanco Animal Health stock a buy?

Elanco Animal Health stock has a consensus rating of Buy, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 5 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Elanco Animal Health is a favorable investment for most analysts.

What is Elanco Animal Health's price target?

Elanco Animal Health's price target, set by 19 Wall Street analysts, averages $24.75 over the next 12 months. The price target range spans from $14 at the low end to $32 at the high end, suggesting a potential 16.20% change from the previous closing price of $21.3.

How does Elanco Animal Health stock forecast compare to its benchmarks?

Elanco Animal Health's stock forecast shows a 16.20% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (20.02%).

What is the breakdown of analyst ratings for Elanco Animal Health over the past three months?

  • December 2025: 12.50% Strong Buy, 62.50% Buy, 18.75% Hold, 0% Sell, 6.25% Strong Sell.
  • November 2025: 13.33% Strong Buy, 53.33% Buy, 26.67% Hold, 0% Sell, 6.67% Strong Sell.
  • October 2025: 6.67% Strong Buy, 53.33% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is Elanco Animal Health’s EPS forecast?

Elanco Animal Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.9, marking a 32.35% increase from the reported $0.68 in 2024. Estimates for the following years are $1.05 in 2026, $1.22 in 2027, and $1.44 in 2028.

What is Elanco Animal Health’s revenue forecast?

Elanco Animal Health's average annual revenue forecast for its fiscal year ending in December 2025 is $4.54B, reflecting a 2.31% increase from the reported $4.44B in 2024. The forecast for 2026 is $4.75B, followed by $5.03B for 2027, and $5.28B for 2028.

What is Elanco Animal Health’s net income forecast?

Elanco Animal Health's net income forecast for the fiscal year ending in December 2025 stands at $445.93M, representing an 31.93% increase from the reported $338M in 2024. Projections indicate $639.6M in 2026, $578.2M in 2027, and $710.55M in 2028.